Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Dmitry Yu. Gvaldin"'
Autor:
Denis S. Kutilin, Vladimir Trifanov, Nataliya N. Timoshkina, Nataliya A. Petrusenko, Dmitry Yu. Gvaldin, Oleg I. Kit
Publikováno v:
Molecular Biology Reports. 47:4233-4243
Despite advances in classification, treatment, and imaging, neuroendocrine tumours remain a clinically complex subject. In this work, we studied the genetic profile of well-differentiated pancreatic neuroendocrine tumours (PanNETs) in a cohort of Cau
Autor:
Ekaterina P. Omelchuk, Emma E. Kechedzhieva, Nataliya N. Timoshkina, Oleg I. Kit, Tatjana V. Ausheva, Larisa N. Vashhenko, Dmitry Yu. Gvaldin
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 22, Iss 1, Pp 1-5 (2021)
Background Genetic predisposition is one of the risk factors for the development of multiple primary cancers (MPCs), the frequency of which increases and ranges from 2 to 17%. This study describes a combination of rare mutations, rs746551843 in the N
Autor:
Dmitry Yu. Gvaldin, Natalya N. Timoshkina, Larisa N. Vashchenko, Tatiana V. Ausheva, Irina R. Dashkova, Ludmila A. Ryadinskaya, Emma E. Kechedzhieva, Liubov Yu Vladimirova
Publikováno v:
Journal of Clinical Oncology. 40:12076-12076
12076 Background: Numerous pharmacogenetic studies have identified genetic polymorphisms (SNPs) associated with an increased risk of anthracycline-mediated cardiotoxicity (AMC). The purpose was to search for SNP-SNP interactions associated with the r
Autor:
Dmitry Yu. Gvaldin, Natalya N. Timoshkina, Larisa N. Vashchenko, Tatiana V. Ausheva, Aleksandr B. Sagakyants, Oksana G. Shulgina, Irina R. Dashkova, Emma E. Kechedzhieva, Liubov Yu Vladimirova
Publikováno v:
Journal of Clinical Oncology. 40:12077-12077
12077 Background: Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of malignancies. Despite their antitumor efficacy there is a risk of cardiotoxic manifestations that reduce the time and quality of life of patient
Autor:
Natalya N. Timoshkina, Natalia A. Petrusenko, Dmitry Yu. Gvaldin, Madina A. Gappoeva, Sergey E. Kavitskiy, Maria A. Cherkes, Ekaterina V. Verenikina, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e17548-e17548
e17548 Background: About 10-15% of malignant ovarian tumors (OC) are associated with hereditary diseases, and about 65-85% of hereditary OC have a mutation in BRCA1/2 genes. The aim of the study was to analyze BRCA1/2 genes hereditary mutation spectr
Autor:
Oleg I. Kit, Anton A. Pushkin, Dmitry Yu. Gvaldin, Inna A. Novikova, Natalya N. Timoshkina, Natalya V. Soldatkina, Yuriy A. Gevorkyan, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15500-e15500
e15500 Background: The immune response plays a key role in the oncogenesis of colorectal cancer. The heterogeneity of the tumor environment determines the need for immunogenetic profiling to identify associations with the implementation of tumor-spec
Autor:
Inna A. Novikova, Elena Yu Zlatnik, Dmitry Yu. Gvaldin, Anton A. Pushkin, Yuriy A. Gevorkyan, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Oleg Yu. Kaymakchi, Oleg I. Kit, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15502-e15502
e15502 Background: The purpose of this study was a comparative analysis of the expression of miRNAs in the tumor and circulating tumor cells (CTCs) in colon cancer (CC). Methods: Expression of seven miRNAs (hsa-let-7i-5p, hsa-miR-126-5p, hsa-miR-143-
Autor:
Arbi M. Nalgiev, Oleg I. Kit, Eduard E. Rostorguev, Nataliya N. Timoshkina, Anton A. Pushkin, Dmitry Yu. Gvaldin
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 21, Iss 1, Pp 1-17 (2020)
Background The purpose of this study was to characterize subtype-specific patterns of mRNA and miRNA expression of gliomas using The Cancer Genome Atlas (TCGA) data to search for genetic determinants that predict prognosis in terms of overall surviva
Autor:
Ekaterina S. Zbrailova, Pavel G. Sakun, Marina A. Engibaryan, Yulia A. Kultysheva, Oleg I. Kit, Vladislav E. Khatyushin, Elena A. Karnaukhova, Marina A. Gusareva, Maria A. Teplyakova, Maksim A. Komandirov, Anton A. Pushkin, Dmitry Yu. Gvaldin, Vitaliy I. Voshedskiy, Stanislav G. Vlasov, Takhmina M. Kecheryukova, Tatiana S. Rogova, Olga G. Rodionova, Anna A. Solntseva
Publikováno v:
Journal of Clinical Oncology. 39:e14025-e14025
e14025 Background: The effectiveness of radiation therapy in the classical and stereotactic treatment regimens of the primary glioblastoma multiforme was analyzed and compared. Methods: 87 patients with primary glioblastoma multiforme were hospitaliz
Autor:
Maksim N. Duritskiy, Vladimir Trifanov, Natalya N. Timoshkina, Petr N. Gabrichidze, Dmitry Yu. Gvaldin, Sergey V. Sanamyants, Oleg I. Kit, Stanislav Stanislavovich Mezentsev, Evgeniy N. Kolesnikov, Umar Muhmadovich Gaziev, Milana Yu. Mesheryakova
Publikováno v:
Journal of Clinical Oncology. 39:e16196-e16196
e16196 Background: Microsatellite instability (MSI), as an acquired feature of malignant tumors, is a predictive and prognostic marker. The less aggressive nature of MSI-positive tumors has been associated with high immunogenicity. In the present stu